Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

PAX5/TEL Acts as a Transcriptional Repressor Causing Down-modulation of CD19, Enhances Migration to CXCL12, and Confers Survival Advantage in pre-BI Cells

Fazio, Grazia, Palmi, Chiara, Rolink, Antonius, Biondi, Andrea, Cazzaniga, Giovanni · 2008 · Cancer Research

Published version of a preprint

Abstract

PAX5 is a transcription factor essential for B-cell development. Recently, it has been found as a frequent target of aberrancies in childhood acute lymphoblastic leukemia (ALL; 30% of B cell ALL cases), showing monoallelic loss, point mutations, or chromosomal translocations. The role of these aberrancies is still poorly understood. We previously cloned the PAX5/TEL fusion gene in a patient affected by B-cell precursor ALL with a t(9;12) translocation. This is the first report investigating the molecular and functional roles of PAX5/TEL protein in vitro from murine wild-type pre-BI cells. We showed that PAX5/TEL protein acts as an aberrant transcription factor with repressor function, recruiting mSin3A, down-regulating B220, CD19, BLNK, MB-1, FLT3, and μ heavy chain expression, thus suggesting a block on B-cell differentiation. In a PAX5-deficient context, the presence of PAX5/TEL did not replace PAX5 functions. PAX5/TEL protein enhances cell migration towards CXCL12, with the overexpression of CXCR4. Moreover, the presence of the fusion gene overcomes interleukin-7 withdrawal and interferes with transforming growth factor-β1 pathway, inducing resistance and conferring cells an advantage in proliferation and survival. Thus, in vitro, the PAX5/TEL protein has a dominant effect on wild-type PAX5, interferes with the process of B-cell differentiation and migration, and induces resistance to apoptosis. Taken together, these phenomena likely represent key events in the process of B-cell transformation. [Cancer Res 2008;68(1):181–9]

Overview

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-07-2778

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 50 references

Cited by

See all 57

Metadata

Authors
Fazio, G., Palmi, C., Rolink, A., Biondi, A., & Cazzaniga, G.
Affiliations
  • Vita-Salute San Raffaele University (IT)
  • 3University of Basel, Basel, Switzerland
  • Azienda Ospedaliera San Gerardo (IT)
Venue
Cancer Research
Published
2008-01-01
Volume
68
Issue
1
Pages
181-189
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W1986199526
Cited by
55
References
50
Citations by year
2025: 1 · 2024: 2 · 2023: 4 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 3 · 2017: 4 · 2016: 2 · 2015: 6 · 2014: 4 · 2013: 1 · 2012: 4
FWCI
6.95
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
PAX5, transcriptional repression, B-cell precursor acute lymphoblastic leukemia, CXCR4, mSin3A, TGF-β1 signaling, apoptosis resistance, B cell transformation
MeSH terms
Animals, B-Lymphocytes, Cell Movement, Cell Nucleus, Cell Survival, Cell Transformation, Neoplastic, Humans, Lymphocyte Activation, Repressor Proteins, Oncogene Proteins, Fusion, Down-Regulation, Interleukin-7, Gene Expression Regulation, Leukemic, Apoptosis, Antigens, CD19, Adaptor Proteins, Signal Transducing, Mice, PAX5 Transcription Factor, CD79 Antigens, fms-Like Tyrosine Kinase 3, Transforming Growth Factor beta1, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Chemokine CXCL12

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PAX5/TEL Acts as a Transcriptional Repressor Causing Down-modulation of CD19, Enhances Migration to CXCL12, and Confers Survival Advantage in pre-BI Cells. https://app.cochat.ai/papers/10.1158/0008-5472.can-07-2778
The paper
Fazio, G., Palmi, C., Rolink, A., Biondi, A., & Cazzaniga, G. (2008). PAX5/TEL Acts as a Transcriptional Repressor Causing Down-modulation of CD19, Enhances Migration to CXCL12, and Confers Survival Advantage in pre-BI Cells. Cancer Research. https://doi.org/10.1158/0008-5472.can-07-2778

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.